Report Detail

Medical Industry Global HIV 1-2 Rapid Test Kits Market Growth (Status and Outlook) 2023-2029

  • RnM4502180
  • |
  • 16 January, 2023
  • |
  • Global
  • |
  • 120 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

The global HIV 1-2 Rapid Test Kits market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for HIV 1-2 Rapid Test Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for HIV 1-2 Rapid Test Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for HIV 1-2 Rapid Test Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key HIV 1-2 Rapid Test Kits players cover Abbott, CTK Biotech, AccuBioTech, Ameritek, Atomo Diagnostics, Autobio Diagnostics, Beckman Coulter, Bioneer and bioLytical Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “HIV 1-2 Rapid Test Kits Industry Forecast” looks at past sales and reviews total world HIV 1-2 Rapid Test Kits sales in 2022, providing a comprehensive analysis by region and market sector of projected HIV 1-2 Rapid Test Kits sales for 2023 through 2029. With HIV 1-2 Rapid Test Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV 1-2 Rapid Test Kits industry.

This Insight Report provides a comprehensive analysis of the global HIV 1-2 Rapid Test Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HIV 1-2 Rapid Test Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV 1-2 Rapid Test Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV 1-2 Rapid Test Kits and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV 1-2 Rapid Test Kits.

This report presents a comprehensive overview, market shares, and growth opportunities of HIV 1-2 Rapid Test Kits market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Blood
Oral Fluid
Urine

Segmentation by application
Offline Sales
Online Sales

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
CTK Biotech
AccuBioTech
Ameritek
Atomo Diagnostics
Autobio Diagnostics
Beckman Coulter
Bioneer
bioLytical Laboratories
Biosynex
Testsea
Cupid Limited
DIALAB
HUMAN
INTEC
J. Mitra & Co
Meril Life Sciences
MP Biomedicals
Medsource Ozone Biomedicals
Nanjing Synthgene Medical Technology
Premier Medical
SD Biosensor
KHB (Shanghai Kehua Bio-Engineering
Türklab A.S.
Trinity Biotech
Wantai BioPharma
Wondfo


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global HIV 1-2 Rapid Test Kits Market Size 2018-2029
    • 2.1.2 HIV 1-2 Rapid Test Kits Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 HIV 1-2 Rapid Test Kits Segment by Type
    • 2.2.1 Blood
    • 2.2.2 Oral Fluid
    • 2.2.3 Urine
  • 2.3 HIV 1-2 Rapid Test Kits Market Size by Type
    • 2.3.1 HIV 1-2 Rapid Test Kits Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global HIV 1-2 Rapid Test Kits Market Size Market Share by Type (2018-2023)
  • 2.4 HIV 1-2 Rapid Test Kits Segment by Application
    • 2.4.1 Offline Sales
    • 2.4.2 Online Sales
  • 2.5 HIV 1-2 Rapid Test Kits Market Size by Application
    • 2.5.1 HIV 1-2 Rapid Test Kits Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global HIV 1-2 Rapid Test Kits Market Size Market Share by Application (2018-2023)

3 HIV 1-2 Rapid Test Kits Market Size by Player

  • 3.1 HIV 1-2 Rapid Test Kits Market Size Market Share by Players
    • 3.1.1 Global HIV 1-2 Rapid Test Kits Revenue by Players (2018-2023)
    • 3.1.2 Global HIV 1-2 Rapid Test Kits Revenue Market Share by Players (2018-2023)
  • 3.2 Global HIV 1-2 Rapid Test Kits Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 HIV 1-2 Rapid Test Kits by Regions

  • 4.1 HIV 1-2 Rapid Test Kits Market Size by Regions (2018-2023)
  • 4.2 Americas HIV 1-2 Rapid Test Kits Market Size Growth (2018-2023)
  • 4.3 APAC HIV 1-2 Rapid Test Kits Market Size Growth (2018-2023)
  • 4.4 Europe HIV 1-2 Rapid Test Kits Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa HIV 1-2 Rapid Test Kits Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas HIV 1-2 Rapid Test Kits Market Size by Country (2018-2023)
  • 5.2 Americas HIV 1-2 Rapid Test Kits Market Size by Type (2018-2023)
  • 5.3 Americas HIV 1-2 Rapid Test Kits Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC HIV 1-2 Rapid Test Kits Market Size by Region (2018-2023)
  • 6.2 APAC HIV 1-2 Rapid Test Kits Market Size by Type (2018-2023)
  • 6.3 APAC HIV 1-2 Rapid Test Kits Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe HIV 1-2 Rapid Test Kits by Country (2018-2023)
  • 7.2 Europe HIV 1-2 Rapid Test Kits Market Size by Type (2018-2023)
  • 7.3 Europe HIV 1-2 Rapid Test Kits Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa HIV 1-2 Rapid Test Kits by Region (2018-2023)
  • 8.2 Middle East & Africa HIV 1-2 Rapid Test Kits Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa HIV 1-2 Rapid Test Kits Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global HIV 1-2 Rapid Test Kits Market Forecast

  • 10.1 Global HIV 1-2 Rapid Test Kits Forecast by Regions (2024-2029)
    • 10.1.1 Global HIV 1-2 Rapid Test Kits Forecast by Regions (2024-2029)
    • 10.1.2 Americas HIV 1-2 Rapid Test Kits Forecast
    • 10.1.3 APAC HIV 1-2 Rapid Test Kits Forecast
    • 10.1.4 Europe HIV 1-2 Rapid Test Kits Forecast
    • 10.1.5 Middle East & Africa HIV 1-2 Rapid Test Kits Forecast
  • 10.2 Americas HIV 1-2 Rapid Test Kits Forecast by Country (2024-2029)
    • 10.2.1 United States HIV 1-2 Rapid Test Kits Market Forecast
    • 10.2.2 Canada HIV 1-2 Rapid Test Kits Market Forecast
    • 10.2.3 Mexico HIV 1-2 Rapid Test Kits Market Forecast
    • 10.2.4 Brazil HIV 1-2 Rapid Test Kits Market Forecast
  • 10.3 APAC HIV 1-2 Rapid Test Kits Forecast by Region (2024-2029)
    • 10.3.1 China HIV 1-2 Rapid Test Kits Market Forecast
    • 10.3.2 Japan HIV 1-2 Rapid Test Kits Market Forecast
    • 10.3.3 Korea HIV 1-2 Rapid Test Kits Market Forecast
    • 10.3.4 Southeast Asia HIV 1-2 Rapid Test Kits Market Forecast
    • 10.3.5 India HIV 1-2 Rapid Test Kits Market Forecast
    • 10.3.6 Australia HIV 1-2 Rapid Test Kits Market Forecast
  • 10.4 Europe HIV 1-2 Rapid Test Kits Forecast by Country (2024-2029)
    • 10.4.1 Germany HIV 1-2 Rapid Test Kits Market Forecast
    • 10.4.2 France HIV 1-2 Rapid Test Kits Market Forecast
    • 10.4.3 UK HIV 1-2 Rapid Test Kits Market Forecast
    • 10.4.4 Italy HIV 1-2 Rapid Test Kits Market Forecast
    • 10.4.5 Russia HIV 1-2 Rapid Test Kits Market Forecast
  • 10.5 Middle East & Africa HIV 1-2 Rapid Test Kits Forecast by Region (2024-2029)
    • 10.5.1 Egypt HIV 1-2 Rapid Test Kits Market Forecast
    • 10.5.2 South Africa HIV 1-2 Rapid Test Kits Market Forecast
    • 10.5.3 Israel HIV 1-2 Rapid Test Kits Market Forecast
    • 10.5.4 Turkey HIV 1-2 Rapid Test Kits Market Forecast
    • 10.5.5 GCC Countries HIV 1-2 Rapid Test Kits Market Forecast
  • 10.6 Global HIV 1-2 Rapid Test Kits Forecast by Type (2024-2029)
  • 10.7 Global HIV 1-2 Rapid Test Kits Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Abbott
    • 11.1.1 Abbott Company Information
    • 11.1.2 Abbott HIV 1-2 Rapid Test Kits Product Offered
    • 11.1.3 Abbott HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Abbott Main Business Overview
    • 11.1.5 Abbott Latest Developments
  • 11.2 CTK Biotech
    • 11.2.1 CTK Biotech Company Information
    • 11.2.2 CTK Biotech HIV 1-2 Rapid Test Kits Product Offered
    • 11.2.3 CTK Biotech HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 CTK Biotech Main Business Overview
    • 11.2.5 CTK Biotech Latest Developments
  • 11.3 AccuBioTech
    • 11.3.1 AccuBioTech Company Information
    • 11.3.2 AccuBioTech HIV 1-2 Rapid Test Kits Product Offered
    • 11.3.3 AccuBioTech HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 AccuBioTech Main Business Overview
    • 11.3.5 AccuBioTech Latest Developments
  • 11.4 Ameritek
    • 11.4.1 Ameritek Company Information
    • 11.4.2 Ameritek HIV 1-2 Rapid Test Kits Product Offered
    • 11.4.3 Ameritek HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Ameritek Main Business Overview
    • 11.4.5 Ameritek Latest Developments
  • 11.5 Atomo Diagnostics
    • 11.5.1 Atomo Diagnostics Company Information
    • 11.5.2 Atomo Diagnostics HIV 1-2 Rapid Test Kits Product Offered
    • 11.5.3 Atomo Diagnostics HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Atomo Diagnostics Main Business Overview
    • 11.5.5 Atomo Diagnostics Latest Developments
  • 11.6 Autobio Diagnostics
    • 11.6.1 Autobio Diagnostics Company Information
    • 11.6.2 Autobio Diagnostics HIV 1-2 Rapid Test Kits Product Offered
    • 11.6.3 Autobio Diagnostics HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 Autobio Diagnostics Main Business Overview
    • 11.6.5 Autobio Diagnostics Latest Developments
  • 11.7 Beckman Coulter
    • 11.7.1 Beckman Coulter Company Information
    • 11.7.2 Beckman Coulter HIV 1-2 Rapid Test Kits Product Offered
    • 11.7.3 Beckman Coulter HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Beckman Coulter Main Business Overview
    • 11.7.5 Beckman Coulter Latest Developments
  • 11.8 Bioneer
    • 11.8.1 Bioneer Company Information
    • 11.8.2 Bioneer HIV 1-2 Rapid Test Kits Product Offered
    • 11.8.3 Bioneer HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Bioneer Main Business Overview
    • 11.8.5 Bioneer Latest Developments
  • 11.9 bioLytical Laboratories
    • 11.9.1 bioLytical Laboratories Company Information
    • 11.9.2 bioLytical Laboratories HIV 1-2 Rapid Test Kits Product Offered
    • 11.9.3 bioLytical Laboratories HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 bioLytical Laboratories Main Business Overview
    • 11.9.5 bioLytical Laboratories Latest Developments
  • 11.10 Biosynex
    • 11.10.1 Biosynex Company Information
    • 11.10.2 Biosynex HIV 1-2 Rapid Test Kits Product Offered
    • 11.10.3 Biosynex HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 Biosynex Main Business Overview
    • 11.10.5 Biosynex Latest Developments
  • 11.11 Testsea
    • 11.11.1 Testsea Company Information
    • 11.11.2 Testsea HIV 1-2 Rapid Test Kits Product Offered
    • 11.11.3 Testsea HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.11.4 Testsea Main Business Overview
    • 11.11.5 Testsea Latest Developments
  • 11.12 Cupid Limited
    • 11.12.1 Cupid Limited Company Information
    • 11.12.2 Cupid Limited HIV 1-2 Rapid Test Kits Product Offered
    • 11.12.3 Cupid Limited HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.12.4 Cupid Limited Main Business Overview
    • 11.12.5 Cupid Limited Latest Developments
  • 11.13 DIALAB
    • 11.13.1 DIALAB Company Information
    • 11.13.2 DIALAB HIV 1-2 Rapid Test Kits Product Offered
    • 11.13.3 DIALAB HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.13.4 DIALAB Main Business Overview
    • 11.13.5 DIALAB Latest Developments
  • 11.14 HUMAN
    • 11.14.1 HUMAN Company Information
    • 11.14.2 HUMAN HIV 1-2 Rapid Test Kits Product Offered
    • 11.14.3 HUMAN HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.14.4 HUMAN Main Business Overview
    • 11.14.5 HUMAN Latest Developments
  • 11.15 INTEC
    • 11.15.1 INTEC Company Information
    • 11.15.2 INTEC HIV 1-2 Rapid Test Kits Product Offered
    • 11.15.3 INTEC HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.15.4 INTEC Main Business Overview
    • 11.15.5 INTEC Latest Developments
  • 11.16 J. Mitra & Co
    • 11.16.1 J. Mitra & Co Company Information
    • 11.16.2 J. Mitra & Co HIV 1-2 Rapid Test Kits Product Offered
    • 11.16.3 J. Mitra & Co HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.16.4 J. Mitra & Co Main Business Overview
    • 11.16.5 J. Mitra & Co Latest Developments
  • 11.17 Meril Life Sciences
    • 11.17.1 Meril Life Sciences Company Information
    • 11.17.2 Meril Life Sciences HIV 1-2 Rapid Test Kits Product Offered
    • 11.17.3 Meril Life Sciences HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.17.4 Meril Life Sciences Main Business Overview
    • 11.17.5 Meril Life Sciences Latest Developments
  • 11.18 MP Biomedicals
    • 11.18.1 MP Biomedicals Company Information
    • 11.18.2 MP Biomedicals HIV 1-2 Rapid Test Kits Product Offered
    • 11.18.3 MP Biomedicals HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.18.4 MP Biomedicals Main Business Overview
    • 11.18.5 MP Biomedicals Latest Developments
  • 11.19 Medsource Ozone Biomedicals
    • 11.19.1 Medsource Ozone Biomedicals Company Information
    • 11.19.2 Medsource Ozone Biomedicals HIV 1-2 Rapid Test Kits Product Offered
    • 11.19.3 Medsource Ozone Biomedicals HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.19.4 Medsource Ozone Biomedicals Main Business Overview
    • 11.19.5 Medsource Ozone Biomedicals Latest Developments
  • 11.20 Nanjing Synthgene Medical Technology
    • 11.20.1 Nanjing Synthgene Medical Technology Company Information
    • 11.20.2 Nanjing Synthgene Medical Technology HIV 1-2 Rapid Test Kits Product Offered
    • 11.20.3 Nanjing Synthgene Medical Technology HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.20.4 Nanjing Synthgene Medical Technology Main Business Overview
    • 11.20.5 Nanjing Synthgene Medical Technology Latest Developments
  • 11.21 Premier Medical
    • 11.21.1 Premier Medical Company Information
    • 11.21.2 Premier Medical HIV 1-2 Rapid Test Kits Product Offered
    • 11.21.3 Premier Medical HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.21.4 Premier Medical Main Business Overview
    • 11.21.5 Premier Medical Latest Developments
  • 11.22 SD Biosensor
    • 11.22.1 SD Biosensor Company Information
    • 11.22.2 SD Biosensor HIV 1-2 Rapid Test Kits Product Offered
    • 11.22.3 SD Biosensor HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.22.4 SD Biosensor Main Business Overview
    • 11.22.5 SD Biosensor Latest Developments
  • 11.23 KHB (Shanghai Kehua Bio-Engineering
    • 11.23.1 KHB (Shanghai Kehua Bio-Engineering Company Information
    • 11.23.2 KHB (Shanghai Kehua Bio-Engineering HIV 1-2 Rapid Test Kits Product Offered
    • 11.23.3 KHB (Shanghai Kehua Bio-Engineering HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.23.4 KHB (Shanghai Kehua Bio-Engineering Main Business Overview
    • 11.23.5 KHB (Shanghai Kehua Bio-Engineering Latest Developments
  • 11.24 Türklab A.S.
    • 11.24.1 Türklab A.S. Company Information
    • 11.24.2 Türklab A.S. HIV 1-2 Rapid Test Kits Product Offered
    • 11.24.3 Türklab A.S. HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.24.4 Türklab A.S. Main Business Overview
    • 11.24.5 Türklab A.S. Latest Developments
  • 11.25 Trinity Biotech
    • 11.25.1 Trinity Biotech Company Information
    • 11.25.2 Trinity Biotech HIV 1-2 Rapid Test Kits Product Offered
    • 11.25.3 Trinity Biotech HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.25.4 Trinity Biotech Main Business Overview
    • 11.25.5 Trinity Biotech Latest Developments
  • 11.26 Wantai BioPharma
    • 11.26.1 Wantai BioPharma Company Information
    • 11.26.2 Wantai BioPharma HIV 1-2 Rapid Test Kits Product Offered
    • 11.26.3 Wantai BioPharma HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.26.4 Wantai BioPharma Main Business Overview
    • 11.26.5 Wantai BioPharma Latest Developments
  • 11.27 Wondfo
    • 11.27.1 Wondfo Company Information
    • 11.27.2 Wondfo HIV 1-2 Rapid Test Kits Product Offered
    • 11.27.3 Wondfo HIV 1-2 Rapid Test Kits Revenue, Gross Margin and Market Share (2018-2023)
    • 11.27.4 Wondfo Main Business Overview
    • 11.27.5 Wondfo Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on HIV 1-2 Rapid Test Kits. Industry analysis & Market Report on HIV 1-2 Rapid Test Kits is a syndicated market report, published as Global HIV 1-2 Rapid Test Kits Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of HIV 1-2 Rapid Test Kits market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,986.56
5,973.12
3,348.90
6,697.80
470,639.40
941,278.80
300,522.60
601,045.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report